-
Company Insights
Catalyst Monitor: Q3 2026 Outlook
This report compiles published, predictive intelligence based on interviews with key opinion leaders (KOLs) on market-moving events that are expected to occur in Q3 2026. GlobalData’s latest report, “Catalyst Monitor Q3 2026”, delivers forward-looking intelligence derived from interviews with key opinion leaders (KOLs), covering trial initiations, completions, Phase III trial results, PDUFA dates, and regulatory filings. The report covers 11 significant catalyst events that are expected to occur in Q3 2026. Some of the catalysts covered in the report, include...
-
Thematic Analysis
Genomics: FutureTech Series
Genomic innovation is accelerating the transition to faster diagnostics, scalable biomanufacturing, and precision therapies. GlobalData’s latest FutureTech Series: Genomics report delivers a comprehensive analysis of the technologies redefining molecular healthcare. The report highlights automated DNA extraction, metagenomic pathogen detection, genome-edited iPSC therapies, plasmid DNA extraction kits, and isothermal DNA amplification, each positioned to address critical challenges in clinical reliability, decentralized testing, and therapeutic accessibility. Using GlobalData’s proprietary Tech Foresights platform, the report examines innovation drivers, challenges, patent leadership, and real-world...
-
Thematic Analysis
Transformational Power of Genomics in Pharma: Strategic Intelligence
Accelerating technologies within the genomics landscape: Several advancements in the pharmaceutical industry have enabled the field of genomics to expand, with researchers innovating new means of therapy for patients with a wide variety of diseases, subsequently enabling in-depth insights to be generated within the genomics landscape. Genomics therapies are paving the way for novel treatments that address the root cause of diseases, allowing additional resources to be allocated for efficient precision and personalized medicine therapies for the treatment of rare...
-
Sector Analysis
Target Validation for Genetic Targets - Innovation Insights, Competitive Analysis, Patents, Drugs, Clinical Trials and Deals
Target validation is a crucial step in the drug discovery process, especially when it comes to genetic targets. This process involves confirming that a specific gene or protein is indeed involved in the disease pathway and is a viable target for therapeutic intervention. In this topic, we will explore the various methods and approaches used for target validation, including genetic knockout studies, RNA interference, and small molecule inhibitors. We will also discuss the challenges and limitations of target validation, as...
-
Analyst Opinions
Unicorn Quest - Innovators in Medical and Pharma
GlobalData's Startup Series report, "Unicorn Quest - Innovators in Medical and Pharma," highlights startups poised to become unicorns in the medical and pharma sectors. It explores how advancements such as AI-driven diagnostics, gene editing, synthetic biology, and personalized healthcare solutions help address unmet medical needs and enhance precision medicine. The report provides insights into startups' growth potential, innovation strategies, and impact, enabling stakeholders to identify promising companies and understand their contributions to the evolving medical and pharmaceutical landscapes. Amidst global...
-
Analyst Opinions
Bacteria - The Next Big Disruptor?
Reasons to Buy the ‘Bacteria – The Next Big Disruptor' innovation radar report: The report provides innovation examples of engineered bacteria use cases across sectors. These innovations present real-world innovation examples related to bacteria. The report casts light on enterprises and startups using engineered bacteria across the sectors in different operations and processes. The report includes the key drivers for the adoption of engineered bacteria, sector impact, and outlook and challenges. The report showcases real-world innovations and illustrative patents by...
-
Company Insights
Top Biotechnology Foreign Direct Investment Companies
Empower your strategies with our Top Biotechnology Foreign Direct Investment Companies report and make more profitable business decisions. Top Biotechnology Foreign Direct Investment Companies report analyzes the most active greenfield FDI investors globally (based on number of projects) in the Biotechnology sector between Q1 2019 and Q2 2024. Additionally, the report highlights where these top Biotechnology investors are investing in what type of operations. The report also provides an overview of notable FDI projects from these top investors. Note: This...
-
Analyst Opinions
Tech, Genes, and Beyond - Startup Transforming Biotech
Biotech Startups Overview Biotech breakthroughs drive cost savings, provide competitive advantages, and showcase efficiency across industries through streamlined manufacturing, custom product development, and resilient supply chains. Biotech advancements are also reshaping the fields of medicine, agriculture, and industry. The following are some of the key highlights of the biotech startups trend analysis: Startups are leading the way for biotechnology advancements. Healthcare demands, government support, and technological breakthroughs are driving the market. AI integration is driving progress in DNA sequencing, drug...
-
Thematic Analysis
Synthetic Biology - Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...
-
Sector Analysis
Key FDI Trends in the Biotechnology Sector
Empower your strategies with our Key FDI Trends in the Biotechnology Sector report and make more profitable business decisions.Key FDI Trends in the Biotechnology Sector report analyzes global greenfield FDI projects within the Biotechnology sector between 2019 and 2022. Additionally, the report highlights: Leading destination and source markets for Biotechnology FDI Top subsectors, themes and business operations for Biotechnology FDI along with key global FDI projects Note: The report will be delivered within 2-3 business days of the purchase, excluding...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.